Mounjaro is second obesity drug to be approved for use in En

Those with BMI of 35 and a comorbidity can now be prescribed tirzepatide and Nice says it is more effective than Wegovy

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Stephen Orahilly , Eli Lilly , Nerys Astbury , National Institute For Health , Cambridge University , Anglia Ruskin University , Novo Nordisk , Oxford University , National Institute , Care Excellence , Simon Cork , Sir Stepheno Rahilly ,